Analyst Price Targets — ATXI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 7, 2024 7:52 am | Jason McCarthy | Maxim Group | $12.00 | $3.39 | StreetInsider | Avenue Therapeutics (ATXI) PT Lowered to $12 at Maxim Group |
Latest News for ATXI
Comparing Avenue Therapeutics (NASDAQ:ATXI) & Graybug Vision (NASDAQ:GRAY)
Insider and Institutional Ownership 17.3% of Avenue Therapeutics shares are held by institutional investors. Comparatively, 49.9% of Graybug Vision shares are held by institutional investors. 8.6% of Avenue Therapeutics shares are held by company insiders. Comparatively, 7.9% of Graybug Vision shares are held by company insiders. Strong institutional ownership is an indication that large money
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ATXI.
U.S. House Trading
No House trades found for ATXI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.